BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 23835793)

  • 1. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis].
    Chen B; Lu LM; Tao L; Zhou L; Li SM; Zhu L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):759-64. PubMed ID: 21092675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of CCR6 and CCR7 in laryngeal squamous cell carcinoma].
    Chen B; Lu L; Tao L; Zhou L; Li S; Zhu L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 24(21):975-9. PubMed ID: 21261017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
    Zhang XX; Kang XM; Zhao AM
    Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma.
    Lee JJ; Chang YL; Lai WL; Ko JY; Kuo MY; Chiang CP; Azuma M; Chen CW; Chia JS
    Head Neck; 2011 Sep; 33(9):1301-8. PubMed ID: 21837700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
    Xu G; Mou Z; Jiang H; Cheng L; Shi J; Xu R; Oh Y; Li H
    Laryngoscope; 2007 May; 117(5):876-80. PubMed ID: 17473687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
    Wang HY; Shi QF; Sun Y; He JJ; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
    Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
    Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
    Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
    Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
    Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
    Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
    Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma.
    Erfani N; Khademi B; Haghshenas MR; Mojtahedi Z; Khademi B; Ghaderi A
    Immunol Invest; 2013; 42(2):81-90. PubMed ID: 23252863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) CD25(+) FoxP3(+) T regulatory cells in subjects responsive or unresponsive to hepatitis B vaccination.
    Li J; Tan D; Liu H; Li K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1046-51. PubMed ID: 22169715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
    Han L; Jiang B; Wu H; Zhang S; Lu X
    Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
    Xu L; Xu W; Qiu S; Xiong S
    Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
    Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
    Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.